1085453-63-9

Basic information

• Product Name: 4-(3-Hydroxyoxetan-3-yl)benzenecarbonitrile
• Synonyms: 4-(3-Hydroxyoxetan-3-yl)benzenecarbonitrile
• CAS NO: 1085453-63-9
• Molecular Weight: 175.187
• Mol File: 1085453-63-9.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 4-(3-Hydroxyoxetan-3-yl)benzenecarbonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(3-Hydroxyoxetan-3-yl)benzenecarbonitrile(1085453-63-9)
• EPA Substance Registry System: 4-(3-Hydroxyoxetan-3-yl)benzenecarbonitrile(1085453-63-9)

Safety Data

• Hazardous Substances Data: 1085453-63-9(Hazardous Substances Data)

Upstream product

• 6704-31-0 oxetan-3-one 
• 3058-39-7 4-iodobenzonitrile 

Downstream Products

• 1085453-66-2 4-(3-methoxyoxetan-3-yl)benzenecarbonitrile 
• 1085453-64-0 4-(3-fluoro-oxetan-3-yl)benzenecarbonitrile 
• 1085453-65-1 4-(3-fluoro-oxetan-3-yl)-N'-hydroxybenzenecarboximide amide 
• 1085453-67-3 N'-hydroxy-4-(3-methoxyoxetan-3-yl)benzenecarboximide amide 
• 1346608-76-1 4-(3-hydroxyoxetan-3-yl)benzoic acid 

Relevant articles and documents

HETEROCYCLICALLY SUBSTITUTED ARYL COMPOUNDS AS HIF INHIBITORS

The present application relates to novel aryl compounds with heterocyclic substituents, processes for their preparation, their use for treatment and/or prevention of diseases and their use for the preparation of medicaments for treatment and/or prevention

HETEROAROMATIC COMPOUNDS FOR USE AS HIF INHIBITORS

The present application relates to novel substituted aryl compounds, processes for their preparation, their use for treatment and/or prevention of diseases and their use for the preparation of medicaments for treatment and/or prevention of diseases, in particular for treatment and/or prevention of hyperproliferative and angiogenic diseases and those diseases which arise from metabolic adaptation to hypoxic states. Such treatments can be carried out as monotherapy or also in combination with other medicaments or further therapeutic measures.

HETEROARYL SUBSTITUTED PYRAZOLE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS

This invention relates to novel heteroaryl substituted pyrazole compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for treating hyper-proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients or therapeutic measures.